MED-X, INC.
Med-X, Inc. filed Amendment No. 2 to its S-1 registration statement for a direct listing of up to 16,248,842 post-split shares of common stock on the Nasdaq Global Market under symbol "MXRX." The company develops natural pest control (Nature-Cide), wellness (Thermal-Aid), and cannabis media (MJT Network) products. A 1-for-2 reverse stock split is approved to take effect immediately before listing. The company has raised approximately $38.1 million in net proceeds from private stock sales since inception at an average post-split price of $2.89 per share.
- 16,248,842 post-split shares registered for resale by existing stockholders via Nasdaq direct listing, not a firm-commitment IPO.
- Company has applied to list on Nasdaq Global Market under symbol "MXRX" using the equity standard; no trading history exists.
- Chairman/CEO controls ~54.3% of total voting power through common stock, options, and Series A super-voting preferred stock (51% voting power).
- A 1-for-2 reverse stock split is approved to take effect immediately before Nasdaq listing; authorized shares remain at 300M.
- From inception through October 14, 2026, the company raised ~$38.1M in net proceeds at an average post-split price of $2.89/share.
Price data unavailable.
A pre-revenue natural-products company with $38.1M raised privately is attempting a rare direct listing on Nasdaq Global Market — bypassing traditional IPO underwriting while carrying concentrated insider voting control.
Med-X operates in the natural pest control and consumer wellness markets with brands Nature-Cide, Thermal-Aid, and Malibu Brands, plus cannabis media platform MJT Network. The direct listing structure mirrors a small but growing trend among companies seeking public market access without traditional underwriting.
Direct listing without firm-commitment underwriting is a novel method with no guaranteed opening price; trading may be more volatile than a traditional IPO. Nasdaq approval is not assured — if denied, the offering terminates. Chairman/CEO holds 54.3% voting control, limiting minority shareholder influence on all major corporate decisions.